Helix BioMedix, Inc. (HXBM)

OTCMKTS · Delayed Price · Currency is USD

1.700

0.00 (0.00%)

At close: Mar 3, 2026

-76.36% (1Y)

Market Cap	382.01K
Revenue (ttm)	2.07M
Net Income (ttm)	-2.58M
Shares Out	224.71K
EPS (ttm)	-15.59
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	100
Average Volume	272
Open	1.700
Previous Close	n/a
Day's Range	1.700 - 1.700
52-Week Range	1.700 - 7.180
Beta	0.52
RSI	20.88
Earnings Date	n/a

About Helix BioMedix

Helix BioMedix, Inc., a biotechnology company, develops peptide-based therapeutics for dermatology and skin health in the United States. It is developing HB4208 for treatment of the rare disease Xeroderma Pigmentosum; and BIOACTIVE SMARTPEPTIDES, a bioactive peptide ingredient for skin care companies. The company was founded in 1988 and is based in Bothell, Washington. [Read more]

Industry Biotechnology

Sector Healthcare

Founded 1988

Employees 8

Stock Exchange OTCMKTS

Ticker Symbol HXBM

Full Company Profile

Financial Performance

In 2011, Helix BioMedix's revenue was $1.89 million, an increase of 122.07% compared to the previous year's $851,683. Losses were -$2.49 million, -67.73% less than in 2010.

Financial Statements

News

There is no news available yet.